ClinicalTrials.gg
Enrolling by invitationNCT05508958Updated Sep 13, 2022

Cup Revisions Through Anterior or Posterolateral Approach: an RCT

An interventional study of Anterior approach and Posterolateral approach in Loosening, Prosthesis, sponsored by Reinier Haga Orthopedisch Centrum. Enrolling by invitation at 1 site in Netherlands. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-09-13.

Sponsored by Reinier Haga Orthopedisch Centrum · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Feb 2026, 9 months ago, but the record still lists the study as enrolling by invitation.
Phase
Not applicable
Study type
Interventional
Enrollment
68
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

With increasing numbers of total hip arthroplasties performed each year, the incidence of problems related to loosening and wear of total hip arthroplasties is expected to also increase. While the anterior approach for primary total hip arthroplasty has demonstrated to result in a faster short-term recovery than the traditional lateral and posterior approach, this effect has not yet been investigated in revision surgery. Accelerating functional outcome may increase patient satisfaction and reduce healthcare costs.

The primary objective is to assess whether isolated cup revision surgery through the anterior approach results in increased functional status and higher patient satisfaction than through the posterolateral approach.

This is a prospective Randomized Controlled Trial (RCT) in which 68 patients will be included (34 per group). Patients will be evaluated preoperatively and 6 weeks, 3 months and 1 year postoperatively.

The main endpoints are functional recovery as measured with the 30-sec Chair Stand Test (30s-CST), 40m Fast Paced Walking Test (40m FPWT) and the Stair Climb Test (SCT).

Secondary endpoints are Modified Borg scale outcomes after the functional tests, Numeric Rating Scale (NRS) for pain (rest/movement), Oxford Hip Score (OHS), HOOS-PS, EQ-5D-5L, satisfaction, cup inclination and complications at 30 days and 90 days postoperatively.

02

Conditions studied

  • Loosening, Prosthesis

Browse trials for

Keywords

  • Isolated cup revision
  • Hip revision surgery
  • Anterior approach
  • Posterolateral approach
  • Cup revision surgery
03

In context

Prosthesis Failure

119 studies on the registry are indexed under Prosthesis Failure; 35 are open to participants now.

This study's planned enrollment of 68 is above the median of 36 across 69 interventional studies indexed under Prosthesis Failure.

Browse Prosthesis Failure studies →

Lead sponsor

Reinier Haga Orthopedisch Centrum is the lead sponsor of 12 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age ≥ 18
  • On waiting list or scheduled for isolated cup revision surgery through anterior or posterolateral approach
  • A good command of the Dutch language

Exclusion criteria

Exclusion Criteria:

  • Revision for confirmed or suspected infection
  • Not suitable for both approaches under study, as judged by orthopaedic surgeon
  • Unable to fully understand study information and to accurately/reliably complete the questionnaires, as judged by researcher and/or orthopaedic surgeon
  • Unable to accurately follow instructions for study procedures / measurements, as judged by researcher and/or orthopaedic surgeon
  • Unwilling to sign form
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
68 participants (estimated)

Study arms

  • Experimental
    Anterior approach

    Cup revision surgery through the anterior approach

    Procedure: Anterior approach

  • Active comparator
    Posterolateral approach

    Cup revision surgery through the posterolateral approach

    Procedure: Posterolateral approach

Interventions

  • ProcedureAnterior approach

    Anterior approach

  • ProcedurePosterolateral approach

    Posterolateral approach

06

What researchers measure

Primary outcomes

  1. Change from baseline 30-sec Chair Stand Test (30s-CST) at 6 weeks

    The 30 second Chair Stand Test (30s-CST) is designed to test the sit-to-stand activity, incorporating lower body strength and dynamic balance, and measures the maximum number of chair stand repetitions possible in a 30 second period. It is part of the core set of tests to assess physical function in patients with hip or knee osteoarthritis or following joint arthroplasty, as recommended by the Osteoarthritis Research Society International (OARSI).

    Time frame: 6 weeks postoperatively

  2. Change from baseline 40m Fast Paced Walk Test (40m FPWT) at 6 weeks

    The 40m Fast Paced Walk Test (40m FPWT) tests walking speed over short distances and changing directions during walking. It is timed over 4 x 10 meters, for a total of 40 meters. It is part of the core set of tests to assess physical function in patients with hip or knee osteoarthritis or following joint arthroplasty, as recommended by the Osteoarthritis Research Society International (OARSI).

    Time frame: 6 weeks postoperatively

  3. Change from baseline Stair Climb Test (SCT) at 6 weeks

    The Stair Climb Test (SCT) is designed to test ascending and descending stair activity, and measures the time in seconds to ascend and descend a flight of stairs. It is part of the core set of tests to assess physical function in patients with hip or knee osteoarthritis or following joint arthroplasty, as recommended by the Osteoarthritis Research Society International (OARSI).

    Time frame: 6 weeks postoperatively

Secondary outcomes

  1. Change from baseline Modified Borg Rating of Perceived Exertion (RPE) scale outcome during 30s-CST at 6 weeks, 3 months and 1 year

    We will use the Borg RPE scale to assess the patients' perception of effort during the functional tasks

    Time frame: Preoperatively, and 6 weeks, 3 months and 1 year postoperatively.

  2. Change from Modified Borg Rating of Perceived Exertion (RPE) scale outcome during 40m FPWT at 6 weeks, 3 months and 1 year

    We will use the Borg RPE scale to assess the patients' perception of effort during the functional tasks

    Time frame: Preoperatively, and 6 weeks, 3 months and 1 year postoperatively.

  3. Change from Modified Borg Rating of Perceived Exertion (RPE) scale outcome during SCT at 6 weeks, 3 months and 1 year

    We will use the Borg RPE scale to assess the patients' perception of effort during the functional tasks

    Time frame: Preoperatively, and 6 weeks, 3 months and 1 year postoperatively.

  4. Change from baseline 30-sec Chair Stand Test (30s-CST) at 6 weeks, 3 months and 1 year

    The 30 second Chair Stand Test (30s-CST) is designed to test the sit-to-stand activity, incorporating lower body strength and dynamic balance, and measures the maximum number of chair stand repetitions possible in a 30 second period. It is part of the core set of tests to assess physical function in patients with hip or knee osteoarthritis or following joint arthroplasty, as recommended by the Osteoarthritis Research Society International (OARSI).

    Time frame: Preoperatively, and 6 weeks, 3 months and 1 year postoperatively

  5. Change from baseline 40m Fast Paced Walk Test (40m FPWT) at 6 weeks, 3 months and 1 year

    The 40m Fast Paced Walk Test (40m FPWT) tests walking speed over short distances and changing directions during walking. It is timed over 4 x 10 meters, for a total of 40 meters. It is part of the core set of tests to assess physical function in patients with hip or knee osteoarthritis or following joint arthroplasty, as recommended by the Osteoarthritis Research Society International (OARSI).

    Time frame: Preoperatively, and 6 weeks, 3 months and 1 year postoperatively

  6. Change from baseline Stair Climb Test (SCT) at 6 weeks, 3 months and 1 year

    The Stair Climb Test (SCT) is designed to test ascending and descending stair activity, and measures the time in seconds to ascend and descend a flight of stairs. It is part of the core set of tests to assess physical function in patients with hip or knee osteoarthritis or following joint arthroplasty, as recommended by the Osteoarthritis Research Society International (OARSI).

    Time frame: Preoperatively, and 6 weeks, 3 months and 1 year postoperatively

  7. Patient reported outcome measure: Pain at rest

    Measured using Numeric Rating Scale (NRS) for pain at rest

    Time frame: Preoperatively, and 6 weeks, 3 months and 1 year postoperatively.

  8. Patient reported outcome measure: Pain during movement

    Measured using Numeric Rating Scale (NRS) for pain during movement

    Time frame: Preoperatively, and 6 weeks, 3 months and 1 year postoperatively.

  9. Patient reported outcome measure: Oxford Hip Score (OHS)

    The Oxford Hip Score (OHS) is a hip specific questionnaire, consisting of 12 items concerning pain and daily functions. In the original scoring, each question is scored on a 5-point Likert scale, ranging from 1 (no pain/easy to do) to 5 (unbearable/impossible to do). The original total score ranges from 12 (best) to 60 (worst) points. It has been developed for total hip surgery. In the revised scoring, each question is scored from 0 (worst) to 4 (best), ranging the total score from 0 (worst) to 48 (best) (20). The revised scoring will be used in this study.

    Time frame: Preoperatively, and 6 weeks, 3 months and 1 year postoperatively.

  10. Patient reported outcome measure: HOOS-PS

    The HOOS-PS is a short measure of physical function for hip osteoarthritis (OA), derived from the original, longer, Hip disability and Osteoarthritis Outcome Score (HOOS). The raw scoring ranges from 0 (none) to 4 (extreme) per question, for a total raw score range of 0 to 20 (lower is less difficulty). The person interval level score ranges, which can be calculated from the total raw score using a nomogram, ranges from 0 (no difficulty) to 100 (extreme difficulty).

    Time frame: Preoperatively, and 6 weeks, 3 months and 1 year postoperatively.

  11. Patient reported outcome measure: EQ-5D-5L

    EuroQol-5D (EQ-5D) is a general health-related quality of life questionnaire and consists of five questions regarding mobility, self-care, usual activities, pain/discomfort and anxiety/depression and one visual analog scale (VAS) to document the perceived quality of life. It is also used to assess quality adjusted life years (QALY).

    Time frame: Preoperatively, and 6 weeks, 3 months and 1 year postoperatively.

  12. Patient reported outcome measure: Satisfaction

    Anchor question regarding how satisfied the subject is (in general) with the results of his/her hip surgery?

    Time frame: 6 weeks, 3 months and 1 year postoperatively.

  13. Cup inclination

    Categorized into ≤35°, 35° - 45° and ≥45°

    Time frame: 6 weeks postoperatively

  14. Complications

    Postoperative complications as recorded in the electronic patient file

    Time frame: 30 days postoperatively and 90 days postoperatively

Other outcomes

  1. Lowgrade infection

    To investigate selection bias caused by loss to follow up, the investigators will also record whether a lowgrade infection was determined during or after revision surgery.

    Time frame: 6 weeks, 3 months and 1 year postoperatively.

07

Study locations

1 site
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2022 (actual). Primary completion is estimated for Feb 2026, 41 months after the start.

Of 48 non-industry interventional studies with no phase under Prosthesis Failure, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 51. This study's planned 41 months is above that.

Counting every sponsor, half of 50 studies reached it within 18 months; a quarter within 9 and three quarters within 42.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 12, 2022
First posted
Aug 19, 2022
StartActual
Sep 8, 2022
Primary completionEst.
Feb 2026
CompletionEst.
Feb 2026
Last update
Sep 13, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 13, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05508958
Lead sponsor
Reinier Haga Orthopedisch Centrum
Responsible party
Sponsor
First posted
Aug 19, 2022
Start date
Sep 8, 2022
Primary completion
Feb 2026 (estimated)
Completion
Feb 2026 (estimated)
Last update
Sep 13, 2022

Study contacts

M. Rutgers, MD
principal investigator · Reinier Haga Orthopedisch Centrum

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion